To maintain a leading position, businesses must develop tactical initiatives by gaining a better grasp of the areas in which huge corporations can intervene. In the health monitoring devices space, this strategic focus is on systems-level problems, such as cybersecurity standardization for streaming patient data or lobbying for favorable national reimbursement codes for RPM. Large corporations intervene by creating ecosystem platforms—think a complete, integrated software/hardware/service stack—that smaller firms cannot replicate due to the immense capital required for cloud infrastructure, data compliance, and global regulatory navigation. Their tactical initiatives involve acquiring software analytics firms to offer predictive, not just descriptive, insights, thus driving the Real Time Health Monitoring Devices Market Growth Dynamics by solving the data overload problem for clinicians.

Firms must also be prepared to recognize newcomers with potentially strong product portfolios and devise effective counter-strategies to acquire a competitive edge. These newcomers are often nimble startups that develop a single, highly innovative component, like a new, extremely power-efficient biosensor or a breakthrough in wireless charging for implanted devices. Their "product portfolio" is their validated proof-of-concept and intellectual property. The most effective counter-strategy for a large, established firm is often a pre-emptive acquisition, absorbing the disruptive technology before it gains critical mass. This allows the incumbent to quickly incorporate the innovation into its massive distribution chain, neutralizing the threat while simultaneously upgrading its own offering and maintaining its competitive edge.